当前位置:首页 - 行情中心 - 天康生物(002100) - 财务分析 - 现金流量表

天康生物

(002100)

  

流通市值:99.80亿  总市值:99.80亿
流通股本:13.65亿   总股本:13.65亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,151,172,156.117,779,967,165.913,298,965,198.778,780,079,803.67
  收到的税费返还-3,850,713.39831,975.87-
  收到其他与经营活动有关的现金25,731,811.79404,550,640.3374,026,164.7840,870,453.39
  经营活动现金流入小计4,176,903,967.8918,188,368,519.6213,373,823,339.428,820,950,257.06
  购买商品、接受劳务支付的现金3,188,954,869.3216,422,448,004.429,767,523,724.086,199,354,467.43
  支付给职工以及为职工支付的现金163,202,298.77803,145,852.11578,269,789.55455,601,245.12
  支付的各项税费41,682,811.42163,319,019.31120,561,124.675,917,849.06
  支付其他与经营活动有关的现金51,692,254.64418,593,903.85556,889,670.68471,051,234.09
  经营活动现金流出小计3,445,532,234.1517,807,506,779.6911,023,244,308.917,201,924,795.7
  经营活动产生的现金流量净额731,371,733.74380,861,739.932,350,579,030.511,619,025,461.36
二、投资活动产生的现金流量:
  收回投资收到的现金255,000,000366,399,874--
  取得投资收益收到的现金9,656,811.64901,697.43--
  处置固定资产、无形资产和其他长期资产收回的现金净额-4,152,333.55686,699.99686,699.99
  投资活动现金流入小计264,656,811.64371,453,904.98686,699.99686,699.99
  购建固定资产、无形资产和其他长期资产支付的现金35,668,974.73378,950,382.13243,060,965.55179,118,903.51
  投资支付的现金145,000,0001,278,350,687.38--
  支付其他与投资活动有关的现金-1,600,000--
  投资活动现金流出小计180,668,974.731,658,901,069.51243,060,965.55179,118,903.51
  投资活动产生的现金流量净额83,987,836.91-1,287,447,164.53-242,374,265.56-178,432,203.52
三、筹资活动产生的现金流量:
  吸收投资收到的现金-200,870--
  其中:子公司吸收少数股东投资收到的现金-200,870--
  取得借款收到的现金1,450,000,0005,363,797,240.223,416,687,240.221,270,987,240.22
  收到其他与筹资活动有关的现金-2,361,300--
  筹资活动现金流入小计1,450,000,0005,366,359,410.223,416,687,240.221,270,987,240.22
  偿还债务支付的现金1,188,664,734.325,408,058,877.064,143,822,504.22,474,714,726.36
  分配股利、利润或偿付利息支付的现金35,202,406.67442,613,863.34493,635,228.87380,793,238.3
  支付其他与筹资活动有关的现金-151,787,775.63--
  筹资活动现金流出小计1,223,867,140.996,002,460,516.034,637,457,733.072,855,507,964.66
  筹资活动产生的现金流量净额226,132,859.01-636,101,105.81-1,220,770,492.85-1,584,520,724.44
四、汇率变动对现金及现金等价物的影响--47,027.52--
五、现金及现金等价物净增加额1,041,492,429.66-1,542,733,557.93887,434,272.1-143,927,466.6
  加:期初现金及现金等价物余额1,410,828,991.972,953,562,549.92,672,585,099.422,953,562,549.9
  期末现金及现金等价物余额2,452,321,421.631,410,828,991.973,560,019,371.522,809,635,083.3
补充资料:
  净利润-300,308,190.47-409,618,129.4
  资产减值准备-46,098,106.21-29,163,891.72
  固定资产和投资性房地产折旧-632,842,447.33-344,520,747.08
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-632,842,447.33-344,520,747.08
  无形资产摊销-26,096,302.42-12,828,955.69
  长期待摊费用摊销-15,690,865.66-8,718,740.07
  处置固定资产、无形资产和其他长期资产的损失--587,072.68-423,913.1
  固定资产报废损失-1,219,644-36,962,429.05
  公允价值变动损失--807,450.93--44,621.09
  财务费用-159,995,645.74-80,437,905
  投资损失--33,827,765.77-7,276,145.63
  递延所得税--12,654,496.6--16,150,641.1
  其中:递延所得税资产减少--13,116,112.93--16,057,576.05
    递延所得税负债增加-461,616.33--93,065.05
  存货的减少--969,266,841.41-808,724,105.36
  经营性应收项目的减少-148,490,390.26-177,525,348.85
  经营性应付项目的增加--236,861,500.52--365,454,339.01
  其他-131,543,845.6--
  现金的期末余额-1,410,828,991.97-2,809,635,083.3
  减:现金的期初余额-2,953,562,549.9-2,953,562,549.9
  现金及现金等价物的净增加额--1,542,733,557.93--143,927,466.6
公告日期2026-04-302026-04-292025-10-302025-08-30
审计意见(境内)标准无保留意见
TOP↑